Experts are rapidly focused on retatrutide, a innovative drug developed by Eli Lilly, as a significant advance in weight loss . Different than many previous approaches, retatrutide is a twin-action compound targeting equally GLP-1 and GIP, substances that influence appetite and blood sugar contr… Read More